SHAH JAISIM 4/A
4/A · Sorrento Therapeutics, Inc. · Filed Sep 18, 2017
Insider Transaction Report
Form 4/AAmended
SHAH JAISIM
Director
Transactions
- Award
Stock Options
2017-09-15+35,000→ 35,000 totalExercise: $1.80Exp: 2027-09-15→ Common Stock (35,000 underlying)
Footnotes (2)
- [F1]This amended report on Form 4 is being filed to amend the Form 4 filed by the reporting person on September 15, 2017 to correct the exercise price, which was inadvertently reported as $1.75.
- [F2]1/12 of the original number of shares subject to this option shall vest and become exercisable following each one month of service thereafter, subject to the reporting person's continued service on the issuer's board of directors on each such date.